Validation of the Screening Instrument: PRISMA-7 for Frailty Among Elderly Hospitalized Danes

• Conditions: Frailty Syndrome

• Registration Number: NCT03999047
• Lead Sponsor: Region Zealand

Brief Summary

The questionnaire PRISMA-7 was originally developed to assess frailty in community dwelling adults. The questionnaire was translated into the Danish language. This instrument was used to screen for frailty among elderly patients (75+) sent home from Nykøbing Falster Hospital after a hospital admission during the period 31. May 2017 until December 31st, 2018. PRISMA results were used to categorize each individula as frail or non-frail. The register of PRISMA results was merged with national registers on use of health serviced in order to investigate if increasing PRISMA score was associated with increasing use of health services.

Detailed Description

Data from PRISMA scores were registered in an EasyTrial database. This database is recognized by the regional health authorities as a safe system to store individual health data. All use of the EasyTRial database is logged. The merging of data from the local EasyTRial database with data from national registries on use of health services and on mortality was permitted by the Danish National Health Data protection authorities.

Study Timeline

• Status Verified: 2019-06
• Study Start: 2019-06-16
• Study First Submitted: 2019-06-16
• Study First Submitted QC: 2019-06-24
• Last Update Submitted: 2019-06-24
• Study First Posted: 2019-06-26
• Last Update Posted: 2019-06-26
• Primary Completion: 2019-12-31
• Study Completion: 2022-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1050

Inclusion Criteria

• 75 years old persons being returned from hospital after a hospital admission and in need of further physical rehabilitation in the community

Exclusion Criteria

Not able to give informed consent or if necessary not having a relative that can give informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality	6 months after PRISMA-7 screening	Mortality
Morbidity	6 months after Prisma-7 screening	Morbidity will be measured by registering Hospital admissions and use of general practitioner

Secondary Outcome Measures

Name	Time	Method
Morbidity	6 months after PRISMA-7 screening	Morbidity will be measured by registering hospital admissions and use og general practitioner
Use of other health services	6 months before PRISMA-7 screening	Home help, rehabilitation services in the municipality

Trial Locations

Locations (1)

Nykøbing Falster Hospital; 🇩🇰 Nykøbing Falster, Denmark